Literature DB >> 9279565

Expression and prognostic value of c-erbB-2 oncogene product in human phaeochromocytomas.

L Castilla-Guerra1, A M Moreno, M C Fernández-Moreno, J C Utrilla, E Fernández, H Galera-Davison.   

Abstract

AIMS: Amplification of c-erbB-2 proto-oncogene has been reported in endocrine tumours, but the results were unclear and no predictive prognostic value has been established in the case of phaeochromocytoma. We investigated the immunohistochemical expression of c-erbB-2 oncogene in 34 cases of human phaeochromocytoma (27 sporadic, seven familial type MEN (multiple endocrine neoplasm)) in order to find out if it could be used to differentiate sporadic and familial forms and whether c-erbB-2 expression is related to tumour biological behaviour. METHODS AND
RESULTS: All the cases showed diffuse, generally heterogeneous, intracytoplasmic granular c-erbB-2 staining. The percentage of tumour cells expressing c-erbB-2 was used as the comparative variable. The percentage of c-erbB-2 positive cells had a statistically significant (P < 0.001) relationship with tumour aggressiveness, as manifested by the presence of distant metastasis or association with other malignant neoplasms. We also found significantly higher levels (P = 0.007) of c-erbB-2 overexpression in MEN phaeochromocytoma than in sporadic cases.
CONCLUSIONS: These results clarify the important role of c-erbB-2 proto-oncogene in the pathogenesis of human phaeochromocytoma and confirm the unfavourable prognostic significance of c-erbB-2 expression.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9279565     DOI: 10.1046/j.1365-2559.1997.2240838.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  5 in total

1.  Losses of chromosomes 1p and 3q are early genetic events in the development of sporadic pheochromocytomas.

Authors:  H Dannenberg; E J Speel; J Zhao; P Saremaslani; E van Der Harst; J Roth; P U Heitz; H J Bonjer; W N Dinjens; W J Mooi; P Komminoth; R R de Krijger
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

2.  A Case of Malignant Pheochromocytoma Presenting 7 Years After the Initial Surgery.

Authors:  Larsa Al-Omaishi; Jonathan Babin; Ralph L Corsetti
Journal:  Ochsner J       Date:  2017

Review 3.  Malignant pheochromocytomas and paragangliomas: a diagnostic challenge.

Authors:  Oliver Gimm; Catherine DeMicco; Aurel Perren; Francesco Giammarile; Martin K Walz; Laurent Brunaud
Journal:  Langenbecks Arch Surg       Date:  2011-11-29       Impact factor: 3.445

4.  Prediction of malignant behavior of pheochromocytomas and paragangliomas using immunohistochemical techniques.

Authors:  Nobue Kumaki; Hiroshi Kajiwara; Kaori Kameyama; Ronald A DeLellis; Sylvia L Asa; R Yoshiyuki Osamura; Hiroshi Takami
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

Review 5.  Molecular genetic alterations in adrenal and extra-adrenal pheochromocytomas and paragangliomas.

Authors:  Hilde Dannenberg; Paul Komminoth; Winand N M Dinjens; Ernst Jan M Speel; Ronald R de Krijger
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.